Figure 6
From: ATG101-related signature predicts prognosis and therapeutic option in hepatocellular carcinoma
The ATS signature is associated with a diverse array of immunomodulators. (A) Positive correlation between the ATS signature and the immunomodulators. (B) Differences in the expression of chemokines between ATS-high and ATS-low groups. (C) Positive correlation between the ATS signature and ICB genes. (D) Differences in the expression of ICB genes between ATS-high and ATS-low states. (E) Correlation between the ATS signature and ICB-related genes in the TCGA pan cancer cohorts.
